Device Ablation

Cardioblate Cryoflex

Payments companies reported to CMS as associated with Cardioblate Cryoflex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$17Kassociated payments (2023-2025)
175clinicians with associated payments
1company reporting

By year

2023 $10K
2024 $6,423
2025 $134

Payments reported as associated with Cardioblate Cryoflex, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $6,872
Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,650
Cardiovascular Disease $2,209
Interventional Cardiology $842
Family $337
Internal Medicine $285

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cardioblate Cryoflex

These are the largest totals companies reported as associated with Cardioblate Cryoflex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Eric Lehr Seattle, WA Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,400.00
Erik Beckmann Minneapolis, MN Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,275.00
Suleyka Olivero-Rivera Bayamon, PR Clinical Cardiac Electrophysiology $1,267.52
Maiwand Mirwais Philadelphia, PA Clinical Cardiac Electrophysiology $347.28
Martin Frey Miami, FL Cardiovascular Disease $311.42
Patrick Hourani Miami, FL Interventional Cardiology $311.42
Abraham Kocheril Champaign, IL Clinical Cardiac Electrophysiology $271.19
James Davenport Oshkosh, WI Cardiovascular Disease $262.66
Alejandro Vidal Margenat Houston, TX Clinical Cardiac Electrophysiology $258.80
Paul Madaj Springfield, MA Clinical Cardiac Electrophysiology $230.79

Prescribed Cardioblate Cryoflex?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.